Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $176.74 million. The enterprise value is $181.73 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 24.38 million shares outstanding. The number of shares has increased by 14.33% in one year.
| Current Share Class | 18.38M |
| Shares Outstanding | 24.38M |
| Shares Change (YoY) | +14.33% |
| Shares Change (QoQ) | +3.01% |
| Owned by Insiders (%) | 12.12% |
| Owned by Institutions (%) | 20.30% |
| Float | 10.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.76 |
| PS Ratio | 2.82 |
| Forward PS | 4.04 |
| PB Ratio | 8.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.31.
| Current Ratio | 1.27 |
| Quick Ratio | 0.89 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.01 |
Financial Efficiency
Return on equity (ROE) is -57.22% and return on invested capital (ROIC) is -10.91%.
| Return on Equity (ROE) | -57.22% |
| Return on Assets (ROA) | -5.86% |
| Return on Invested Capital (ROIC) | -10.91% |
| Return on Capital Employed (ROCE) | -16.86% |
| Revenue Per Employee | $1.38M |
| Profits Per Employee | -$213,122 |
| Employee Count | 41 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, Journey Medical has paid $121,000 in taxes.
| Income Tax | 121,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.80% in the last 52 weeks. The beta is 0.81, so Journey Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +71.80% |
| 50-Day Moving Average | 7.19 |
| 200-Day Moving Average | 5.98 |
| Relative Strength Index (RSI) | 47.98 |
| Average Volume (20 Days) | 167,615 |
Short Selling Information
The latest short interest is 1.21 million, so 4.96% of the outstanding shares have been sold short.
| Short Interest | 1.21M |
| Short Previous Month | 1.11M |
| Short % of Shares Out | 4.96% |
| Short % of Float | 11.00% |
| Short Ratio (days to cover) | 9.97 |
Income Statement
In the last 12 months, Journey Medical had revenue of $56.40 million and -$8.74 million in losses. Loss per share was -$0.40.
| Revenue | 56.40M |
| Gross Profit | 37.52M |
| Operating Income | -6.86M |
| Pretax Income | -3.94M |
| Net Income | -8.74M |
| EBITDA | -2.94M |
| EBIT | -6.86M |
| Loss Per Share | -$0.40 |
Full Income StatementBalance Sheet
The company has $20.29 million in cash and $25.28 million in debt, giving a net cash position of -$4.98 million or -$0.20 per share.
| Cash & Cash Equivalents | 20.29M |
| Total Debt | 25.28M |
| Net Cash | -4.98M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 19.25M |
| Book Value Per Share | 0.82 |
| Working Capital | 10.79M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.71M |
| FCF Per Share | -$0.11 |
Full Cash Flow StatementMargins
Gross margin is 66.52%, with operating and profit margins of -12.16% and -15.49%.
| Gross Margin | 66.52% |
| Operating Margin | -12.16% |
| Pretax Margin | -15.28% |
| Profit Margin | -15.49% |
| EBITDA Margin | -5.21% |
| EBIT Margin | -12.16% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.33% |
| Shareholder Yield | -14.33% |
| Earnings Yield | -4.94% |
| FCF Yield | -1.53% |
Analyst Forecast
The average price target for Journey Medical is $12.50, which is 72.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.50 |
| Price Target Difference | 72.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 0.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.11 |
| Piotroski F-Score | 1 |